Commonwealth Equity Services LLC trimmed its position in GE HealthCare Technologies Inc. by 34.4% in the third quarter, according to the latest 13F filing with the SEC. The fund sold 91,088 shares, reducing its holding to 173,486 shares valued at approximately USD 13.03 million. This move contrasts with other large investors such as Mirae Asset Global Investments Co. Ltd., which increased its stake by 4.2%, and Wedge Capital Management L L P NC, which initiated a new position worth roughly USD 26.86 million during the same period. Institutional ownership remains high at 82.06%, underscoring the stock’s prominence among major asset managers and hedge funds.

In its most recent quarter, GE HealthCare reported adjusted earnings of USD 1.07 per share, exceeding consensus estimates by USD 0.02, with revenue of USD 5.14 billion, up 5.8% year-over-year and surpassing forecasts by USD 70 million. The company achieved a net margin of 10.94% and a return on equity of 22.52%. Management has issued guidance for fiscal 2025 earnings in the range of USD 4.51 to USD 4.63 per share, aligning with the average analyst projection of USD 4.68. These results reflect steady demand for its diagnostic imaging systems and lifecycle services, while the outlook incorporates ongoing investments in software and analytics platforms.

GE HealthCare declared a quarterly dividend of USD 0.035 per share, payable on February 13 to shareholders of record as of January 9, representing an annualized yield of 0.2% and a payout ratio of 2.89%. On the research front, seven analysts maintain a buy recommendation, while seven rate the stock as hold, resulting in a consensus rating of Moderate Buy. Price targets in recent reports range from the high eighties to mid-nineties, reflecting confidence in the company’s cash flow generation and margin expansion, balanced against competition in advanced imaging and regulatory pressures on refurbished equipment markets.